Date | Name | Title | Action | No Shares | Price Per Share |
---|---|---|---|---|---|
Insider Transactions For LLY | |||||
2025-08-15 | Montarce, Lucas | EVP & CFO | Purchased | 715 | $691.79 |
2025-08-13 | Van, Naarden Jacob | EVP & Pres., Lilly Oncology | Purchased | 1000 | $647.36 |
2025-08-13 | Alvarez, Ralph | Director | Purchased | 758 | $660.25 |
2025-08-12 | Fyrwald, J Erik | Director | Purchased | 686 | $642.00 |
2025-08-12 | Fyrwald, J Erik | Director | Purchased | 879 | $642.59 |
2025-08-12 | Sulzberger, Gabrielle | Director | Purchased | 117 | $641.18 |
2025-08-12 | Skovronsky, Daniel | EVP, CSO & Pres. LRL & LLY Imm | Purchased | 1000 | $634.41 |
2025-08-12 | Ricks, David A | Director, President, Chair, and CEO | Purchased | 1632 | $644.77 |
2025-08-11 | Yuffa, Ilya | EVP&Pres, LLY USA&Global Capab | Sold | 1250 | $627.01 |
2025-08-08 | Jackson, Jamere | Director | Purchased | 200 | $639.56 |
2025-08-01 | Seymour, Melissa | EVP, Global Quality | Sold | 952 | $0.00 |
2025-08-01 | Seymour, Melissa | EVP, Global Quality | Purchased | 952 | $0.00 |
2025-08-01 | Seymour, Melissa | EVP, Global Quality | Sold | 426.92 | $740.07 |
2025-07-24 | Lilly, Endowment Inc | 10% Owner | Sold | 63566 | $803.48 |
2025-07-24 | Lilly, Endowment Inc | 10% Owner | Sold | 22138 | $806.60 |
2025-07-24 | Lilly, Endowment Inc | 10% Owner | Sold | 36183 | $807.49 |
2025-07-24 | Lilly, Endowment Inc | 10% Owner | Sold | 8367 | $808.34 |
2025-07-24 | Lilly, Endowment Inc | 10% Owner | Sold | 46771 | $805.33 |
2025-07-24 | Lilly, Endowment Inc | 10% Owner | Sold | 102975 | $804.48 |
2025-07-21 | Hedley, Mary Lynne | Director | Purchased | 13.01 | $762.18 |